J Pharm Pharmaceut Sci (www.ualberta.ca/~csps) 7(2):92-185, 2004

 

Molecule to market: biotechnologically-derived molecules vs. traditional small chemical entities.

Proceedings of the
CSPS 7th Annual Symposium on Pharmaceutical Sciences

The Sheraton Vancouver Wall Centre
Vancouver, British Columbia, Canada

June 9-12, 2004

Canadian Society for Pharmaceutical Sciences
Société canadienne des sciences Pharmaceutiques

http://www.ualberta.ca/~csps

Sponsors
Bristol-Myers Squibb Company, Merck Frosst, Novartis, Gattefosse, GlaxoSmithKline, Angiotech Pharmaceuticals Inc., Biovail Contract Research, Patheon, Taro, Purdue, University of Alberta

Exhibitors
Algorithme Pharma, ATS Scientific Inc., Biovail Contract Research, BRI Biopharmaceutical Research Inc., Cantest, Cedarlane Laboratories Limited, FTS Systems, Gattefosse Canada, International Specialty Products, Northern Lipids Inc., MicroCal, sfbc Anapharm, Waters

CSPS Scientific Planning Committee Chairs
Gordon McKay, Pharmalytics Inc., Saskatchewan; Dion Brocks, University of Alberta, Edmonton

Proceedings of the CSPS 7th Annual Symposium on Pharmaceutical Sciences (PDF)

AFPC Poster Session (PDF)

CSPS Awards Booklet 2004 (PDF)

Photos of the Symposium, taken by E.Vadas

Photos of the Symposium, taken by I.McGilveray

 

JPPS Contents

 

Published by the Canadian Society for Pharmaceutical Sciences.
 Copyright © 1999 by the Canadian Society for Pharmaceutical Sciences.
 http://www.ualberta.ca/~csps